Stimcell Energetics Inc STME

$0.15 -0.10 (-41.18%)

Valuation

Market cap
3,108,000
Revenue TTM
$0
Net income TTM
$-900,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
-0.35

Trading

Volume
1,000
Avg volume
4,874
Day's range
$0.15 – $0.17
Shares out
21,141,000
Stochastic %K
0%
Beta
—
Analysts
Hold
Price target
—

Price

Company profile

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home Sy...

Show more

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of the shoulder, waist, back, neck, upper and lower extremities (arms and legs). The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Industry
Medical Devices
Sector
Healthcare
Phone
844 238 2692
Website
https://stimcell.com
Address
1130 Pender Street, West, Suite 820, Vancouver, Canada

Latest news

No headlines yet.